# A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

> clinical trial · VERIFIED · 2026-06-11

Status: NOT_YET_RECRUITING · Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. · Condition: Castration-resistant Prostate Cancer

- Company: Sichuan Baili Pharmaceutical Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07641855

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.